Avalo Therapeutics (AVTX) Share-based Compensation (2014 - 2026)
Avalo Therapeutics (AVTX) reported Share-based Compensation of $5.31 million for Q2 2026, up 95.2% from $2.72 million a year earlier and up 48.4% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Avalo Therapeutics' Share-based Compensation came in at $16.54 million, up 54.4% year-over-year; for FY2025, it was $13.62 million, up 132.8% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $5.85 million in FY2024 (+68.3%), $3.48 million in FY2023 (-54.0%), $7.55 million in FY2022 (-7.6%) and $8.17 million in FY2021 (+20.4%).
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q1 2022.
- Year over year, Share-based Compensation has now increased in each of the last eight quarters, with growth averaging 186.5% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q2 2025 (growth of 477.1%); the low point was Q1 2023 (a decline of 83.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.58 million (Q1 2026), $4.51 million (Q4 2025) and $3.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Avalo Therapeutics | 657.52 Mn | 657.52 Mn | - | 5.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31 Mn |
| Mar 31, 2026 | 3.58 Mn |
| Dec 31, 2025 | 4.51 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 2.90 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 471,000.00 |
| Mar 31, 2024 | 629,000.00 |
| Dec 31, 2023 | 776,000.00 |
| Sep 30, 2023 | 953,000.00 |
| Jun 30, 2023 | 893,000.00 |
| Mar 31, 2023 | 855,000.00 |
| Dec 31, 2022 | 843,000.00 |
| Sep 30, 2022 | 731,000.00 |
| Jun 30, 2022 | 668,000.00 |
| Mar 31, 2022 | 5.31 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 1.76 Mn |
API Access
Avalo Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();